InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,159.59
(
-0.86%
)
Post# of 252494
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119982
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: db7 post# 240553

Wednesday, 12/01/2021 6:28:31 PM

Wednesday, December 01, 2021 6:28:31 PM

Post# of 252494
From a strictly economic standpoint, ABUS should settle the patent case, IMO, because MRNA has the resources to drag the case out for years and ABUS is hardly a lock to prevail in an eventual trial (and appeal).

However, I have a hunch that ABUS is disinclined to settle; they want to have something cooking to divert investors’ attention from the not-so-hot HBV pipeline.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up